Incidence and characteristics of ventricular tachycardia in patients after percutaneous coronary revascularization of chronic total occlusions.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 28 04 2019
accepted: 08 11 2019
entrez: 23 11 2019
pubmed: 23 11 2019
medline: 21 3 2020
Statut: epublish

Résumé

This study sought to investigate the prevalence of ventricular tachycardia after percutaneous coronary intervention (PCI) of chronic total occlusion (CTO). PCI of a CTO is associated with improvement of the left ventricular ejection fraction and possibly associated with reduced mortality. However, benefits of CTO-PCI must be weighed against a higher risk of procedure-related complications. The incidence of new-onset ventricular tachycardia after a successful CTO-PCI has not been investigated so far. In this retrospective registry we seek to describe characteristics and predictors of occurrence of post-procedural ventricular tachycardias. Between 2010 and 2015, 485 patients underwent successful CTO-PCI at Heart Center Leipzig. Of them, 342 had complete follow-up and were further analyzed. Ventricular tachycardias were detected in 9 (2.6%) patients. All of them were monomorphic ventricular tachycardias occurring in median 1 day (interquartile range [IQR] 0.25-4.75 days) after PCI and caused prolongation of the hospital stay. Patients with ventricular tachycardia were older, had worse left ventricular ejection fraction (mean 33.1%, SD 5.9%) and more frequently a CTO of an infarct-related artery. The target vessel was not associated with the occurrence of ventricular arrhythmias. In multivariable analysis, only impaired left ventricular systolic function was an independent predictor for procedure-related ventricular tachycardia. Mortality rates were not different between patients with or without ventricular tachycardia. Ventricular tachycardia can occur early after CTO-PCI as possible reperfusion arrhythmia and poorer left ventricular ejection fraction is the only independent predictor for onset. Although the occurrence of ventricular tachycardia after CTO-PCI seems not to influence mortality, awareness of this possible complication and longer monitoring may be recommended.

Sections du résumé

OBJECTIVES
This study sought to investigate the prevalence of ventricular tachycardia after percutaneous coronary intervention (PCI) of chronic total occlusion (CTO).
BACKGROUND
PCI of a CTO is associated with improvement of the left ventricular ejection fraction and possibly associated with reduced mortality. However, benefits of CTO-PCI must be weighed against a higher risk of procedure-related complications. The incidence of new-onset ventricular tachycardia after a successful CTO-PCI has not been investigated so far. In this retrospective registry we seek to describe characteristics and predictors of occurrence of post-procedural ventricular tachycardias.
METHODS AND RESULTS
Between 2010 and 2015, 485 patients underwent successful CTO-PCI at Heart Center Leipzig. Of them, 342 had complete follow-up and were further analyzed. Ventricular tachycardias were detected in 9 (2.6%) patients. All of them were monomorphic ventricular tachycardias occurring in median 1 day (interquartile range [IQR] 0.25-4.75 days) after PCI and caused prolongation of the hospital stay. Patients with ventricular tachycardia were older, had worse left ventricular ejection fraction (mean 33.1%, SD 5.9%) and more frequently a CTO of an infarct-related artery. The target vessel was not associated with the occurrence of ventricular arrhythmias. In multivariable analysis, only impaired left ventricular systolic function was an independent predictor for procedure-related ventricular tachycardia. Mortality rates were not different between patients with or without ventricular tachycardia.
CONCLUSION
Ventricular tachycardia can occur early after CTO-PCI as possible reperfusion arrhythmia and poorer left ventricular ejection fraction is the only independent predictor for onset. Although the occurrence of ventricular tachycardia after CTO-PCI seems not to influence mortality, awareness of this possible complication and longer monitoring may be recommended.

Identifiants

pubmed: 31756220
doi: 10.1371/journal.pone.0225580
pii: PONE-D-19-05445
pmc: PMC6874319
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0225580

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Circulation. 2014 Feb 18;129(7):728-36
pubmed: 24211823
Int J Cardiol. 2015;187:90-6
pubmed: 25828320
Catheter Cardiovasc Interv. 2019 May 1;93(6):1025-1032
pubmed: 30723999
JACC Cardiovasc Interv. 2013 Feb;6(2):128-36
pubmed: 23352817
J Am Coll Cardiol. 2012 Mar 13;59(11):991-7
pubmed: 22402070
Europace. 2017 Feb 1;19(2):267-274
pubmed: 28175266
J Cardiovasc Electrophysiol. 2015 May;26(5):532-9
pubmed: 25598359
Heart. 2016 Sep 15;102(18):1486-93
pubmed: 27164918
Eur Heart J Acute Cardiovasc Care. 2015 Feb;4(1):51-9
pubmed: 25063574
Circ Cardiovasc Interv. 2015 Jul;8(7):e002171
pubmed: 26162857
Clin Res Cardiol. 2009 Jul;98(7):435-41
pubmed: 19294443
J Mol Cell Cardiol. 2015 Jan;78:90-9
pubmed: 25268650
J Invasive Cardiol. 2014 Mar;26(3):100-5
pubmed: 24610502
Circ Res. 2004 Apr 30;94(8):1142-9
pubmed: 15016734
Int J Cardiol. 2014 Jun 15;174(2):243-8
pubmed: 24768461
J Am Coll Cardiol. 2001 Aug;38(2):409-14
pubmed: 11499731
Am Heart J. 2010 Jul;160(1):179-87
pubmed: 20598990
Int J Cardiovasc Imaging. 2017 Jun;33(6):815-823
pubmed: 28091872
PLoS One. 2014 Aug 12;9(8):e103850
pubmed: 25117457
Chin Med J (Engl). 1996 Apr;109(4):282-5
pubmed: 8758288
Europace. 2008 Aug;10(8):988-97
pubmed: 18483000
Isr Med Assoc J. 2007 Jan;9(1):21-3
pubmed: 17274350
JACC Cardiovasc Interv. 2015 Feb;8(2):245-253
pubmed: 25700746
HeartRhythm Case Rep. 2016 Jul 22;2(6):462-464
pubmed: 28491737
Am J Physiol Heart Circ Physiol. 2013 Jan 15;304(2):H318-27
pubmed: 23125211
Bratisl Lek Listy. 1998 Mar-Apr;99(3-4):162-71
pubmed: 9919746
Am J Cardiol. 2005 May 1;95(9):1088-91
pubmed: 15842978
Circulation. 2005 Oct 11;112(15):2364-72
pubmed: 16216980
Circ Arrhythm Electrophysiol. 2012 Feb;5(1):147-54
pubmed: 22205684
Chin Med J (Engl). 2013 Mar;126(6):1086-91
pubmed: 23506583
J Invasive Cardiol. 2014 Sep;26(9):427-32
pubmed: 25198485
JACC Cardiovasc Interv. 2017 May 8;10(9):879-888
pubmed: 28473110
Catheter Cardiovasc Interv. 2014 Oct 1;84(4):637-43
pubmed: 24142769
Catheter Cardiovasc Interv. 2015 Apr;85(5):781-94
pubmed: 25338948

Auteurs

Sebastian König (S)

Department of Electrophysiology, Heart Center Leipzig at University of Leipzig, Leipzig, Sachsen, Germany.

Enno Boudriot (E)

Department of Cardiology, Heart Center Leipzig at University of Leipzig, Leipzig, Sachsen, Germany.

Arash Arya (A)

Department of Electrophysiology, Heart Center Leipzig at University of Leipzig, Leipzig, Sachsen, Germany.

Julia-Anna Lurz (JA)

Department of Electrophysiology, Heart Center Leipzig at University of Leipzig, Leipzig, Sachsen, Germany.

Marcus Sandri (M)

Department of Cardiology, Heart Center Leipzig at University of Leipzig, Leipzig, Sachsen, Germany.

Sandra Erbs (S)

Department of Cardiology, Heart Center Leipzig at University of Leipzig, Leipzig, Sachsen, Germany.

Holger Thiele (H)

Department of Cardiology, Heart Center Leipzig at University of Leipzig, Leipzig, Sachsen, Germany.

Gerhard Hindricks (G)

Department of Electrophysiology, Heart Center Leipzig at University of Leipzig, Leipzig, Sachsen, Germany.
Leipzig Heart Institute, Leipzig, Sachsen, Germany.

Borislav Dinov (B)

Department of Electrophysiology, Heart Center Leipzig at University of Leipzig, Leipzig, Sachsen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH